GB5D and SciMed Partners Announce Agreement to Collaborate

GB5D helps Companies Expand beyond
Their Domestic Market

The World Just Got a Little Bit Smaller


SciMed Partners and GB5D have agreed to cooperate in order to better help foreign life sciences, medtech, and healthcare technology companies with US market entry.

With several hundred years of combined biotech, medtech, life sciences, healthcare technology and international business development expertise, we can efficiently help entrepreneurial companies in these sectors gain a foothold in the largest medical market in the world.

    • Perform market and product gap analysis
    • Assist in choosing the appropriate method of entry –  distributor or agent, licensing, subsidiary or joint venture.
    • Develop a company’s strategic business development plan.
    • Assist with tactics as needed.

Chances are one of our over 60 senior-level experts has been exposed to the type of products you want to bring to market.


We are focused on the challenges faced by life sciences and medtech companies that want to expand into overseas markets. We are intimately familiar with such strategic issues as:

  • FDA regulatory approvals
  • Payment and reimbursement
  • The US healthcare system
  • Risk management

To discuss your US market entry plan please contact or

Leave a Reply

Your email address will not be published.